Lazard Asset Management’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
AIM
Lazard Asset Management's VCYT Position: Q2 2026 in Review
Lazard Asset Management reduced its Veracyte (VCYT) stake by 4.1% in Q2 2026, selling an estimated $80.8K and leaving 45,617 shares worth $2.68M. The position accounts for ﹤0.01% of the portfolio, ranked #846.
Lazard Asset Management first reported a position in VCYT in Q3 2019 and has held it in 25 quarters since. The position peaked at $4.13M in Q2 2025. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.
- Lazard Asset Management held 45,617 shares of Veracyte worth $2.68M as of Q2 2026.
- Lazard Asset Management sold 1,926 Veracyte shares in Q2 2026, an estimated $80.8K.
- Veracyte made up ﹤0.01% of Lazard Asset Management's portfolio in Q2 2026, its #846 holding.
- Lazard Asset Management first reported a position in Veracyte in Q3 2019 and has held it in 25 quarters since.
- Lazard Asset Management's Veracyte position peaked at $4.13M in Q2 2025.
- 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.
Based on Lazard Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.